Health-related quality of life and cost comparison of adjuvant capecitabine versus 5-fluorouracil/leucovorin in stage III colorectal cancer patients

Abstract

The purpose of this study was to compare health-related quality of life (HRQoL) and costs associated with 2 adjuvant chemotherapy regimens [capecitabine-based therapy versus 5-fluorouracil/leucovorin (5-FU/LV)-based therapy] in stage III colorectal cancer patients. We conducted a prospective, open-label, observational, multicenter study from July 2008 to… (More)
DOI: 10.1007/s11136-014-0773-x

Topics

7 Figures and Tables

Slides referencing similar topics